SAVA Q1 2018 Earnings — Cassava Sciences, Inc. Revenue & Financial Results | Market Cap Arena

SAVACassava Sciences, Inc.

$115M

Q1 2018 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$1,068

Operating Income

-$2M

Net Income

-$2M

EPS (Diluted)

$-0.33

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$2M

Free Cash Flow

-$2M

Stock-Based Comp.

$802,000

Balance Sheet

Total Assets

$11M

Total Liabilities

$758,000

Stockholders' Equity

$10M

Cash & Equivalents

$11M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$1,068	-$1,388	+23.1%
Operating Income	-$2M	-$3M	+21.6%
Net Income	-$2M	-$3M	+21.3%